Literature DB >> 33819142

Iron parenteral administration: an expert opinion on the assessment of fetal wellbeing.

Antonio Ragusa1,2, Alessandro Svelato1, Matteo Bolcato3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33819142      PMCID： PMC8971023          DOI： 10.2450/2021.0063-21

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  5 in total

1.  Fetal bradycardia following maternal administration of low-molecular-weight intravenous iron.

Authors:  T Woodward; T Kay; M Rucklidge
Journal:  Int J Obstet Anesth       Date:  2015-02-03       Impact factor: 2.603

2.  The daily-practiced post-partum hemorrhage management: an Italian multidisciplinary attended protocol.

Authors:  G Affronti; V Agostini; A Brizzi; L Bucci; E De Blasio; M G Frigo; C Giorgini; M Messina; A Ragusa; F Sirimarco; A Svelato
Journal:  Clin Ter       Date:  2017 Sep-Oct

Review 3.  Evaluation and management of abnormal uterine bleeding in premenopausal women.

Authors:  Mary Gayle Sweet; Tarin A Schmidt-Dalton; Patrice M Weiss; Keith P Madsen
Journal:  Am Fam Physician       Date:  2012-01-01       Impact factor: 3.292

4.  Evaluation of the Reported Rates of Severe Hypersensitivity Reactions Associated with Ferric Carboxymaltose and Iron (III) Isomaltoside 1000 in Europe Based on Data from EudraVigilance and VigiBase™ between 2014 and 2017.

Authors:  Birgit Ehlken; Lennart Nathell; Annegret Gohlke; Derya Bocuk; Massoud Toussi; Stefan Wohlfeil
Journal:  Drug Saf       Date:  2019-03       Impact factor: 5.606

5.  Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy.

Authors:  Bernd Froessler; Tijana Gajic; Gustaaf Dekker; Nicolette A Hodyl
Journal:  Arch Gynecol Obstet       Date:  2018-05-08       Impact factor: 2.344
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.